{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T07:02:25Z","timestamp":1760598145607,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009169","name":"Assiut University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009169","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cytotoxic (CD8) T-cells and natural killer (NK) cells have a significant immune function role. The ongoing stimulation of immunity and the excessive release of proinflammatory cytokines observed in pediatric patients with Gaucher disease (GD) can affect immune cells. Few studies have looked at the proportion of cytotoxic CD8 T-cells and their subsets in children with GD. A prospective case\u2013control study was performed involving twenty pediatric patients with type 1 GD and twenty healthy age-matched controls. All patients received regular enzyme replacement therapy (ERT) for at least 6 months before the study. Complete blood count and flow cytometric analyses of CD8 T, Tc1, Tc2, NK, and NK T-cells were performed. GD patients showed significantly increased of CD8 T, Tc1 and significantly decreased NK cells frequencies when compared to healthy controls. However, no significant difference in Tc2 and NK T-cells was found between the studied groups. GD patients on regular ERT have increased CD8+ T-cell frequencies, predominantly Tc1, together with a reduction in NK cells than in healthy controls. These crucial immunological changes may contribute to some extent to the pathogenesis and the progression of GD.<\/jats:p>","DOI":"10.1038\/s41598-022-08843-4","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T10:04:30Z","timestamp":1648029870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Upregulation of Cytotoxic T-cells in pediatric patients with Gaucher disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Asmaa M.","family":"Zahran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8473-6116","authenticated-orcid":false,"given":"Khaled","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid I.","family":"Elsayh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madleen Adel A.","family":"Abdou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir M.","family":"Abo-Elgheet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esraa M.","family":"Eloseily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaimaa M.","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabaan","family":"Sror","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal-Alkhateeb","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira","family":"Elhoufey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliaa","family":"Ghandour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa S.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"key":"8843_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-020-01300-w","author":"AM Zahran","year":"2021","unstructured":"Zahran, A. M. et al. Dendritic cells and monocyte subsets in children with Gaucher disease. Pediatr. Res. https:\/\/doi.org\/10.1038\/s41390-020-01300-w (2021).","journal-title":"Pediatr. Res."},{"issue":"2","key":"8843_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bcmd.2014.12.003","volume":"55","author":"N Bettman","year":"2015","unstructured":"Bettman, N. et al. Impaired migration capacity in monocytes derived from patients with Gaucher disease. Blood Cells Mol. Dis. 55(2), 180\u2013186. https:\/\/doi.org\/10.1016\/j.bcmd.2014.12.003 (2015).","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"8843_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00005-016-0421-y","volume":"65","author":"AM Zahran","year":"2017","unstructured":"Zahran, A. M. et al. Activated and memory T lymphocytes in children with Gaucher disease. Arch. Immunol. Ther. Exp. 65(3), 263\u2013269. https:\/\/doi.org\/10.1007\/s00005-016-0421-y (2017).","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"1","key":"8843_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bcmd.2015.10.001","volume":"56","author":"P Giraldo","year":"2016","unstructured":"Giraldo, P. et al. Patients with type 1 Gaucher disease in Spain: A cross-sectional evaluation of health status. Blood Cells Mol. Dis. 56(1), 23\u201330. https:\/\/doi.org\/10.1016\/j.bcmd.2015.10.001 (2016).","journal-title":"Blood Cells Mol. Dis."},{"issue":"2","key":"8843_CR5","first-page":"205","volume":"10","author":"V Barak","year":"1999","unstructured":"Barak, V. et al. Cytokines in Gaucher\u2019s disease. Eur. Cytokine Netw. 10(2), 205\u2013210 (1999).","journal-title":"Eur. Cytokine Netw."},{"issue":"3","key":"8843_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1615\/critrevoncog.2013004503","volume":"18","author":"MK Pandey","year":"2013","unstructured":"Pandey, M. K. & Grabowski, G. A. Immunological cells and functions in Gaucher disease. Crit. Rev. Oncog. 18(3), 197\u2013220. https:\/\/doi.org\/10.1615\/critrevoncog.2013004503 (2013).","journal-title":"Crit. Rev. Oncog."},{"issue":"6","key":"8843_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00005-014-0293-y","volume":"62","author":"HW Mittr\u00fccker","year":"2014","unstructured":"Mittr\u00fccker, H. W. et al. Heterogeneity in the differentiation and function of CD8+ T cells. Arch. Immunol. Ther. Exp. 62(6), 449\u2013458. https:\/\/doi.org\/10.1007\/s00005-014-0293-y (2014).","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"11","key":"8843_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri3307","volume":"12","author":"SM Kaech","year":"2012","unstructured":"Kaech, S. M. & Cui, W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 12(11), 749\u2013761. https:\/\/doi.org\/10.1038\/nri3307 (2012).","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"8843_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1006\/bcmd.1999.0237","volume":"25","author":"L Lacerda","year":"1999","unstructured":"Lacerda, L. et al. T cell numbers relate to bone involvement in Gaucher disease. Blood Cells Mol. Dis. 25(2), 130\u2013138. https:\/\/doi.org\/10.1006\/bcmd.1999.0237 (1999).","journal-title":"Blood Cells Mol. Dis."},{"key":"8843_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","volume":"25","author":"A Bendelac","year":"2007","unstructured":"Bendelac, A. et al. The biology of NKT cells. Annu. Rev. Immunol. 25, 297\u2013336. https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141711 (2007).","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"8843_CR11","first-page":"149","volume":"23","author":"Y Burstein","year":"1987","unstructured":"Burstein, Y. et al. Abnormalities of cellular immunity and natural killer cells in Gaucher\u2019s disease. J. Clin. Lab. Immunol. 23(3), 149\u2013151 (1987).","journal-title":"J. Clin. Lab. Immunol."},{"issue":"4","key":"8843_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bcmd.2014.07.020","volume":"53","author":"P Rodic","year":"2014","unstructured":"Rodic, P. et al. Flow cytometric assessment of lymphocyte subsets in Gaucher type 1 patients. Blood Cells Mol. Dis. 53(4), 169\u2013170. https:\/\/doi.org\/10.1016\/j.bcmd.2014.07.020 (2014).","journal-title":"Blood Cells Mol. Dis."},{"key":"8843_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-immunol-032713-120243","volume":"32","author":"M Salio","year":"2014","unstructured":"Salio, M. et al. Biology of CD1- and MR1-restricted T cells. Annu. Rev. Immunol. 32, 323\u2013366. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120243 (2014).","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"8843_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jaut.2008.07.003","volume":"31","author":"E Zigmond","year":"2008","unstructured":"Zigmond, E. et al. NKT lymphocyte polarization determined by microenvironment signaling: a role for CD8+ lymphocytes and beta-glycosphingolipids. J. Autoimmun. 31(2), 188\u2013195. https:\/\/doi.org\/10.1016\/j.jaut.2008.07.003 (2008).","journal-title":"J. Autoimmun."},{"issue":"3","key":"8843_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1365-3083.2012.02750.x","volume":"76","author":"S Rhost","year":"2012","unstructured":"Rhost, S. et al. Immunomodulatory type II natural killer T lymphocytes in health and disease. Scand. J. Immunol. 76(3), 246\u2013255. https:\/\/doi.org\/10.1111\/j.1365-3083.2012.02750.x (2012).","journal-title":"Scand. J. Immunol."},{"issue":"11","key":"8843_CR16","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.4049\/jimmunol.1301176","volume":"191","author":"E Hams","year":"2013","unstructured":"Hams, E. et al. Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J. Immunol. 191(11), 5349\u20135353. https:\/\/doi.org\/10.4049\/jimmunol.1301176 (2013).","journal-title":"J. Immunol."},{"key":"8843_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.bcmd.2016.10.016","volume":"68","author":"MC Matta","year":"2018","unstructured":"Matta, M. C. et al. Could enzyme replacement therapy promote immune tolerance in Gaucher disease type 1?. Blood Cells Mol. Dis. 68, 200\u2013202. https:\/\/doi.org\/10.1016\/j.bcmd.2016.10.016 (2018).","journal-title":"Blood Cells Mol. Dis."},{"key":"8843_CR18","doi-asserted-by":"publisher","first-page":"CD0010324","DOI":"10.1002\/14651858.CD010324.pub2","volume":"3","author":"E Shemesh","year":"2015","unstructured":"Shemesh, E. et al. Enzyme replacement and substrate reduction therapy for Gaucher disease. Cochrane Database Syst. Rev. 3, CD0010324. https:\/\/doi.org\/10.1002\/14651858.CD010324.pub2 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"8843_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.molmed.2003.08.004","volume":"9","author":"DA Brooks","year":"2003","unstructured":"Brooks, D. A. et al. Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder. Trends Mol. Med. 9(10), 450\u2013453. https:\/\/doi.org\/10.1016\/j.molmed.2003.08.004 (2003).","journal-title":"Trends Mol. Med."},{"issue":"12","key":"8843_CR20","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/ajh.21280","volume":"83","author":"N Weinreb","year":"2008","unstructured":"Weinreb, N. et al. A benchmark analysis of the achievement of therapeutic goals for type 1 Gaucher disease patients treated with imiglucerase. Am. J. Hematol. 83(12), 890\u2013895. https:\/\/doi.org\/10.1002\/ajh.21280 (2008).","journal-title":"Am. J. Hematol."},{"issue":"6","key":"8843_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.blre.2016.05.003","volume":"30","author":"M Regenboog","year":"2016","unstructured":"Regenboog, M. et al. Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications. Blood Rev. 30(6), 431\u2013437. https:\/\/doi.org\/10.1016\/j.blre.2016.05.003 (2016).","journal-title":"Blood Rev."},{"key":"8843_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/B978-0-7020-6896-6.00017-X","volume-title":"Clinical Immunology","author":"SL Nutt","year":"2019","unstructured":"Nutt, S. L. & Huntington, N. D. Cytotoxic T lymphocytes and natural killer cells. In Clinical Immunology 5th edn 247\u2013259 (Elsevier, 2019).","edition":"5"},{"issue":"5","key":"8843_CR23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2141.2005.05503.x","volume":"129","author":"A Balreira","year":"2005","unstructured":"Balreira, A. et al. Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC-class II: Monocytes from Gaucher disease patients as a model. Br. J. Haematol. 129(5), 667\u2013676. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05503.x (2005).","journal-title":"Br. J. Haematol."},{"issue":"12","key":"8843_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168135","volume":"11","author":"RP Limgala","year":"2016","unstructured":"Limgala, R. P. et al. Time of initiating enzyme replacement therapy affects immune abnormalities and disease severity in patients with Gaucher disease. PLoS ONE 11(12), e0168135. https:\/\/doi.org\/10.1371\/journal.pone.0168135 (2016).","journal-title":"PLoS ONE"},{"key":"8843_CR25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.clinbiochem.2004.06.008","volume":"37","author":"A Wajner","year":"2004","unstructured":"Wajner, A. et al. Biochemical characterisation of chitotriosidase enzyme. Comparison between normal individuals and patients with Gaucher and Niemann-Pick diseases. Clin. Biochem. 37, 893\u2013897. https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.06.008 (2004).","journal-title":"Clin. Biochem."},{"key":"8843_CR26","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/intimm\/dxh328","volume":"15","author":"M Van Eijk","year":"2005","unstructured":"Van Eijk, M. et al. Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int. Immunol. 15, 1505\u20131512. https:\/\/doi.org\/10.1093\/intimm\/dxh328 (2005).","journal-title":"Int. Immunol."},{"issue":"1","key":"8843_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00403-008-0891-9","volume":"301","author":"A Kuhn","year":"2009","unstructured":"Kuhn, A. et al. CD4(+) CD25 (+) regulatory T cells in human lupus erythematosus. Arch. Dermatol. Res. 301(1), 71\u201381. https:\/\/doi.org\/10.1007\/s00403-008-0891-9 (2009).","journal-title":"Arch. Dermatol. Res."},{"issue":"4","key":"8843_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bcmd.2013.01.001","volume":"50","author":"C Braudeau","year":"2013","unstructured":"Braudeau, C. et al. Altered innate function of plasmacytoid dendritic cells restored by enzyme replacement therapy in Gaucher disease. Blood Cells Mol. Dis. 50(4), 281\u2013288. https:\/\/doi.org\/10.1016\/j.bcmd.2013.01.001 (2013).","journal-title":"Blood Cells Mol. Dis."},{"issue":"4","key":"8843_CR29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2567.2010.03360.x","volume":"131","author":"N Schleinitz","year":"2010","unstructured":"Schleinitz, N. et al. Natural killer cells in human autoimmune diseases. Immunology 131(4), 451\u2013458. https:\/\/doi.org\/10.1111\/j.1365-2567.2010.03360.x (2010).","journal-title":"Immunology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08843-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08843-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08843-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:12:01Z","timestamp":1669338721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08843-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8843"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-08843-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2022,3,23]]},"assertion":[{"value":"18 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4977"}}